Functional recombinant human anti-HBV antibody expressed in milk of transgenic mice

Transgenic Research

Volumn 21, Issue 5, 2012, Pages 1085-1091

  Zhang, Ran ^a   Cui, Dan ^a   Wang, Hong ^a   Li, Chuan ^b   Yao, Xin ^c   Zhao, Yaofeng ^a   Liang, Mifang ^b   Li, Ning ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Milk; Monoclonal antibody; Transgenic mice

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B SURFACE ANTIGEN RECEPTOR; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MICROINJECTION; MILK; MOUSE; PLASMID; TRANSGENE; TRANSGENIC MOUSE; UDDER; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULIN G; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MICROINJECTIONS; MILK; PLASMIDS; RECEPTORS, ANTIGEN; RECOMBINANT PROTEINS; TRANSGENES;

ANIMALIA; HEPATITIS B VIRUS; MAMMALIA; MUS MUSCULUS;

EID: 84865984999     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-012-9589-z     Document Type: Article

References (23)

1. CDC (2008) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Morb Mortal Wkly Rep 57(RR-08): 1-20.
2. Choi T, Huang M, Gorman C, Jaenisch R (1991) A generic intron increases gene expression in transgenic mice. Mol Cell Biol 11: 3070-3074.
3. Chung JH, Bell AC, Felsenfeld G (1997) Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci USA 94: 575-580.
4. Dimitrov DS, Marks JD (2009) Therapeutic antibodies: current state and future trends-is a paradigm change coming soon? Methods Mol Biol 525: 1-27.
5. Dyck MK, Lacroix D, Pothier F, Sirard MA (2003) Making recombinant proteins in animals-different systems, different applications. Trends Biotechnol 21: 394-399.
6. Eren R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, Ben-Moshe O, Kitchinzky A, Berr S, Gopher J, Zauberman A, Galun E, Shouval D, Daudi N, Eid A, Jurim O, Magnius LO, Hammas B, Reisner Y, Dagan S (2000) Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology 32: 588-596.
7. Farid SS (2007) Process economics of industrial monoclonal antibody manufacture. J Chromatogr B Anal Technol Biomed Life Sci 848: 8-18.
8. Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot E, Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S (2002) Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology 35: 673-679.
9. Guo Y, Liang M, Bi S (2004) Development of recombinant human-derived IgG antibody against HBsAg. Chin J Exp Clin Virol 18: 105-108.
10. Hogan B, Beddington R, Costantini F, Lacy E (1994) Manipulating the mouse embryo, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
11. Kidd-Ljunggren K, Miyakawa Y, Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83: 1267-1280.
12. Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
13. Marasco WA, Sui J (2007) The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol 25: 1421-1434.
14. McKnight RA, Shamay A, Sankaran L, Wall RJ, Hennighausen L (1992) Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci USA 89: 6943-6947.
15. Ning D, Junjian X, Xunzhang W, Wenyin C, Qing Z, Kuanyuan S, Guirong R, Xiangrong R, Qingxin L, Zhouyao Y (2003) Expression, purification, and characterization of humanized anti-HBs Fab fragment. J Biochem 134: 813-817.
16. Okanoue T, Minami M (2006) Update of research and management of hepatitis B. J Gastroenterol 41: 107-118.
17. Pauwelyn K, Cassiman D, Laleman W, Verslype C, Monbaliu D, Aerts R, van Steenbergen W, Pirenne J, Nevens F (2010) Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation. Transplant Proc 42: 4399-4402.
18. Recillas-Targa F, Pikaart MJ, Burgess-Beusse B, Bell AC, Litt MD, West AG, Gaszner M, Felsenfeld G (2002) Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc Natl Acad Sci USA 99: 6883-6888.
19. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
20. Shouval D, Samuel D (2000) Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology 32: 1189-1195.
21. Whitelaw CB, Archibald AL, Harris S, McClenaghan M, Simons JP, Clark AJ (1991) Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice. Transgenic Res 1: 3-13.
22. Zhang W, Czupryn MJ (2002) Free sulfhydryl in recombinant monoclonal antibodies. Biotechnol Prog 18: 509-513.
23. Zhang P, Yu MY, Venable R, Alter HJ, Shih JW (2006) Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees. Proc Natl Acad Sci USA 103: 9214-9219.